☆ 4.7 Article

Development of an Oral Salmonella-Based Vaccine Platform against SARS-CoV-2

VACCINES (2022)

Related references

Note: Only part of the references are listed.

Review Medicine, Research & Experimental

Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development

Kevin Ita

Summary: The COVID-19 pandemic has spurred the development of various drugs and vaccines worldwide, utilizing small-molecule drugs, vaccines, and immunoinformatics. While many vaccines are in clinical trials, mRNA and DNA vaccines still await regulatory approval.

ARCHIVES OF MEDICAL RESEARCH (2021)

Add to Collection

Review Gastroenterology & Hepatology

COVID-19: Discovery, diagnostics and drug development

Tarik Asselah et al.

Summary: COVID-19 started in Wuhan in 2019 and has become a global pandemic. The virus responsible, SARS-CoV-2, shares a high sequence identity with bat- and pangolin-derived coronaviruses. Risk factors for SARS-CoV-2 infection include age, obesity, diabetes, and hypertension.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Review Immunology

COVID-19 vaccine: where are we now and where should we go?

Saman Soleimanpour et al.

Summary: The SARS-CoV-2 has caused a global pandemic with the potentially fatal disease, COVID-19, leading to the urgent need for effective vaccines and drugs. Research on COVID-19 vaccine candidates is ongoing, with challenges including finding virulence ability of the virus, suitable experimental models, immune-response study, and designing clinical trials.

EXPERT REVIEW OF VACCINES (2021)

Add to Collection

Review Microbiology

SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights

Swapnil B. Kadam et al.

Summary: The outbreak of COVID-19 marked the third spillover of an animal coronavirus to humans in the last 20 years, likely originating from bats and possibly transmitted to humans via unknown intermediate host (potentially a pangolin). The causative pathogen, SARS-CoV-2, shares genetic similarities with bat and pangolin coronaviruses in terms of protein structure and genome, suggesting a zoonotic origin.

JOURNAL OF BASIC MICROBIOLOGY (2021)

Add to Collection

Article Infectious Diseases

Side effects and perceptions following Sinopharm COVID-19 vaccination

Balsam Qubais Saeed et al.

Summary: This study investigated the side effects of Sinopharm COVID-19 vaccine in individuals in the United Arab Emirates, finding that the main reason for vaccine hesitancy was perceived lack of effectiveness. Results showed that side effects post vaccination varied slightly among different age groups, but were generally mild and predictable.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Review Pharmacology & Pharmacy

COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies

Kajal Rawat et al.

Summary: COVID-19, caused by a new strain of betacoronavirus named as SARS-CoV-2, poses a huge burden on public health and global economies due to its high transmission rate. Developing vaccines is essential for preventing the spread of the virus and reducing mortality.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines

Edward H. Livingston

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Multidisciplinary Sciences

Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes

Ziliang Zhou et al.

Summary: SARS-CoV-2 ORF7a interacts efficiently with human CD14(+) monocytes, triggering inflammatory responses such as decreased HLA expression and increased production of proinflammatory cytokines. This suggests that ORF7a may be a key immunomodulating factor in the severe immune response seen in COVID-19 patients.

ISCIENCE (2021)

Add to Collection

Review Pharmacology & Pharmacy

mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

Linde Schoenmaker et al.

Summary: The current mRNA-lipid nanoparticle COVID-19 vaccines require storage at low temperatures due to instability. Improving mRNA nucleotide composition, understanding the impact of mRNA environment within LNPs, and exploring drying techniques can enhance vaccine stability.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Add to Collection

Letter Dermatology

Improving cultural competency and practicing cultural humility in dermatologic training: Skin of color education and board certification

Trisha Kaundinya et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors

Yipeng Cao et al.

Summary: Studying the SARS-CoV-2 E protein is crucial for understanding the pathogenesis of the virus and plays a key role in disease treatment. While there are similarities between the SARS-CoV-2 and SARS-CoV E proteins, further specific research on the SARS-CoV-2 E protein is still needed.

PROTEIN SCIENCE (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement

Rumiana Tenchov et al.

Summary: Lipid nanoparticles (LNPs) have become promising vehicles in the pharmaceutical industry for delivering various therapeutics, particularly highlighted in the COVID-19 mRNA vaccines. LNPs exhibit versatility and physical stability, allowing for targeted delivery of therapeutic drugs to specific locations within the body. Liposomes, an early version of LNPs, have already been widely applied in medical practice.

ACS NANO (2021)

Add to Collection

Review Immunology

Supply and delivery of vaccines for global health

Jean-Louis Excler et al.

Summary: Vaccines developed in high-income countries have successfully reduced the global burden of infectious diseases, saving millions of lives annually. However, global implementation of vaccines, especially for those without incentives, can be delayed. Poverty-associated infectious diseases in low and middle-income countries such as Group A Streptococcus, invasive non-typhoid salmonella, and schistosomiasis could benefit from increased support for vaccine development.

CURRENT OPINION IN IMMUNOLOGY (2021)

Add to Collection

Review Immunology

Humoral Immunity vs. Salmonella

Akiko Takaya et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

Muhammad Adnan Shereen et al.

JOURNAL OF ADVANCED RESEARCH (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China

Annoor Awadasseid et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Add to Collection

Article Oncology

Application of genetically engineered Salmonella typhimurium for interferon-gamma-induced therapy against melanoma

Wonsuck Yoon et al.

EUROPEAN JOURNAL OF CANCER (2017)

Add to Collection

Article Oncology

Effective Cancer Vaccine Platform Based on Attenuated Salmonella and a Type III Secretion System

Xin Xu et al.

CANCER RESEARCH (2014)

Add to Collection

Review Immunology

Toll-like receptor-based adjuvants: enhancing the immune response to vaccines against infectious diseases of chicken

Shishir Kumar Gupta et al.

EXPERT REVIEW OF VACCINES (2014)

Add to Collection

Review Immunology

Salmonella as a vaccine delivery vehicle

Kenneth L. Roland et al.

EXPERT REVIEW OF VACCINES (2013)

Add to Collection

Article Immunology

Salmonella Vaccine Vectors Displaying Delayed Antigen Synthesis In Vivo To Enhance Immunogenicity

Shifeng Wang et al.

INFECTION AND IMMUNITY (2010)

Add to Collection

Article Biochemical Research Methods

Enzymatic assembly of DNA molecules up to several hundred kilobases

Daniel G. Gibson et al.

NATURE METHODS (2009)

Add to Collection

Article Medicine, Research & Experimental

In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines

Hiroyoshi Nishikawa et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.